Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...
A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...
The designation will provide Lundbeck with the possibility of rolling reviews and detailed guidance to streamline the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback